Carbon Underwriting, a specialist independent managing general underwriter and Lloyd’s syndicate, has announced its entry into the international healthcare market with the appointment of Martin Leeks as head of international medical malpractice.
The company, known for its innovative underwriting solutions and expertise in delegated authority portfolios, will focus its new international healthcare division on delegated portfolios in Australia, Canada, the UK, and Europe, underwriting on Lloyd’s paper.
Leeks, who joins Carbon with over 35 years of underwriting experience, brings a wealth of expertise in international casualty and medical malpractice.
Prior to joining Carbon, he held a senior position at Everest Group and has a proven track record of developing profitable portfolios. In his new role, Leeks will lead Carbon’s ambitious plans to deliver exceptional underwriting solutions in the healthcare sector.
Leeks’ arrival comes shortly after Carbon appointed Alex Poracchia as its chief financial officer, further strengthening its leadership team.
Nick Tye, founder and CEO of Carbon, highlighted the significance of the appointment, saying, “Martin’s appointment is a fantastic step forward for Carbon as we launch our international healthcare division. This is more than just a strategic expansion – it’s a statement of our intent to bring fresh energy, innovation, and insight to the healthcare market. With the support of both Carbon’s analytics and our collaborative culture, I have no doubt Martin will support our growth into healthcare with distinction. His ambition, expertise, and vision are just what we need to establish Carbon as a leader in international healthcare underwriting. Welcome aboard, Martin, I am excited to see what we achieve together.”
Commenting on his new role, Martin Leeks said, “The international healthcare market is ripe with opportunity, and I couldn’t be more thrilled to join the fast-growing Carbon team. This is a company with a great reputation, that doesn’t just talk about innovation, it lives and breathes it, from its people to its technology. With unparalleled data insights and a culture that fosters creativity and support, I’m confident we’ll deliver a market-leading portfolio.”
Copyright © 2025 InsurTech Analyst
